(Q40147163)

17 September 2017

1 reference

title

Gonadal injury resulting from chemotherapy (English)

1 reference

17 September 2017

Gonadal Injury Resulting From Chemotherapy (English)

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

2 October 2023

1 reference

antineoplastic combined chemotherapy protocols

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340475

2 October 2023

author name string

R. M. Chapman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6340475

2 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6340475

2 October 2023

publication date

1 January 1983

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fajim.1983.4.1-2.149

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

https://onlinelibrary.wiley.com/doi/full/10.1002/ajim.1983.4.1-2.149

2 October 2023

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

American Journal of Industrial Medicine

2 October 2023

published in

1 reference

17 September 2017

volume

4

1 reference

17 September 2017

issue

1-2

1 reference

17 September 2017

page(s)

149-161

1 reference

Morphological study of the ovaries of leukaemic children

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FAJIM.4700040114

Testicular Damage Due to Cytotoxic Drugs and Recovery after Cessation of Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJIM.4700040114

Gonadal dysfunction in patients receiving chemotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJIM.4700040114

Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJIM.4700040114

Cyclophosphamide and the prepubertal testis

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Testicular function in boys after chemotherapy for acute lymphoblastic leukemia

2 October 2023

3

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Return of spermatogenesis after stopping cyclophosphamide therapy

2 October 2023

4

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Effect of cytotoxic therapy on sexuality and gonadal function

2 October 2023

5

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cyclical combination chemotherapy and gonadal function. Retrospective study in males

2 October 2023

6

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function

2 October 2023

7

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cytotoxic-induced ovarian failure in Hodgkin's disease. II. Effects on sexual function

2 October 2023

8

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Reproductive Potential after Treatment for Hodgkin's Disease

2 October 2023

10

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cyclophosphamide and the prepubertal gonad: a negative report

2 October 2023

14

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture

2 October 2023

15

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Methotrexate and fertility in men

2 October 2023

16

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

CHLORAMBUCIL THERAPY FOR LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA

2 October 2023

17

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Sterility and testicular atrophy related to cyclophosphamide therapy

2 October 2023

18

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

1-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers

2 October 2023

19

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

CHLORAMBUCIL-PREDNISOLONE THERAPY FOR DISSEMINATED BREAST CARCINOMA

2 October 2023

20

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Busulfan (1, 4-dimethanesulfonyloxybutane, myleran); summary of clinical results

2 October 2023

21

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

The prevention of endometrial cancer in postmenopausal women with progestogens

2 October 2023

22

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Studies of human semen in topical corticosteroid-treated and in methotrexate-treated psoriatics

2 October 2023

24

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome

2 October 2023

25

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens

2 October 2023

26

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Female Reproductive Potential after Treatment for Hodgkin's Disease

2 October 2023

28

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Testicular atrophy in a prepubescent male after cyclophosphamide therapy

2 October 2023

29

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Gonadotropin responses to luteinizing releasing factor in boys treated with cyclophosphamide for nephrotic syndrome

2 October 2023

31

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cyclophosphamide and reproductive function.

2 October 2023

32

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Effects of cancer chemotherapeutic agents on testicular DNA synthesis in the rat. Evaluation of a short-term test for studies of the genetic toxicity of chemicals and drugs in vivo

2 October 2023

33

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia

2 October 2023

34

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty.

2 October 2023

35

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

2 October 2023

36

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Treatment of chronic granulocytic leukemia with myleran

2 October 2023

37

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cytotoxic effects of chemotherapeutic drugs on mouse testis cells

2 October 2023

38

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Effect of prednisolone upon normal and pathologic human spermatogenesis

2 October 2023

39

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Treatment of spinal osteoporosis in postmenopausal women

2 October 2023

40

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Menopausal estrogen therapy and hip fractures

2 October 2023

41

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Gonadal Function in Children With Nephrosis Treated With Cyclophosphamide

2 October 2023

42

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome

2 October 2023

43

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cyclophosphamide therapy and sterility

2 October 2023

44

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cyclophosphamide and the pubertal testis

2 October 2023

45

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma

2 October 2023

46

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Ovarian function in patients receiving adjuvant chemotherapy for breast cancer

2 October 2023

48

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy

2 October 2023

49

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease

2 October 2023

51

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

The effect of combination chemotherapy on ovarian, hypothalamic and pituitary function in patients with breast cancer

2 October 2023

52

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Effects of cancer chemotherapy on gonadal function of patients

2 October 2023

53

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Endocrine function following the treatment of acute leukemia in childhood

2 October 2023

54

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease

2 October 2023

57

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Carcinogenic and other adverse effects of procarbazine in nonhuman primates

2 October 2023

58

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Effects of Childhood Leukemia and Chemotherapy on Puberty and Reproductive Function in Girls

2 October 2023

59

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Two Cases of Busulfan Toxicity

2 October 2023

60

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents

2 October 2023

61

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

The histological effects of nitrogen mustards on human tumors and tissues

2 October 2023

62

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Psoriasis, methotrexate, and oligospermia

2 October 2023

63

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Sterility and cyclophosphamide

2 October 2023

64

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Cyclophosphamide-Induced Ovarian Failure

2 October 2023

65

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium

2 October 2023

67

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male

2 October 2023

68

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

Long-term results of treatment of children and adolescents with Hodgkin's disease

2 October 2023

70

1 reference

https://api.crossref.org/works/10.1002/AJIM.1983.4.1-2.149

2 October 2023

Identifiers

10.1002/AJIM.4700040114

1 reference

17 September 2017

1 reference